AEON · AEON Biopharma, Inc.

NYSEHealthcareBiotechnology

Aeon Biopharma Inc Is A Biopharmaceutical Company Focused On The Development Of Abp-450 (Prabotulinumtoxina), A Biosimilar To Botox (Onabotulinumtoxina), For Therapeutic Indications. The Company Is Advancing Abp-450 Through The Biosimilar Regulatory Pathway And Holds Development And Commercialization Rights Across Multiple International Markets.

HealthcareNYSEUSLow Float

$0.94

+57.1% latest move

Price & move as of the most recent catalyst (Mar 3) — not a live quote.

FLOAT

11.4M

FREE FLOAT %

23%

SHARES O/S

49.9M

MARKET CAP

$12.3M

EXCHANGE

NYSE

COUNTRY

AEON Catalyst History

Other and Special SituationsMar 3, 2025 · 6:54pm ET

AEONAEON Biopharma, Inc.

AEON Biopharma Announces Participation in Leerink Global Healthcare Conference

Marc Forth, AEON’s President and CEO, to present.

Be early on the next AEON spark.

Day Trader Sniper alerts you the instant a setup like this triggers.

How it works Download Free →